FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and more specifically to an antidiabetic composition. What is offered is a pharmaceutical composition containing Glimepiride, poloxamer, sodium croscarmellose and other excipients - povidone, lactose monohydrate, microcrystalline cellulose, stearic acid salt and a colourant.
EFFECT: pharmaceutical composition is characterised by high therapeutic activity, satisfactory technical characteristics and shelf life of more than 2 years.
11 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL ANTIDIABETIC COMPOSITION AND METHOD OF OBTAINING ANTIDIABETIC COMPOSITION | 2011 |
|
RU2482846C2 |
| PELLETISED DRUG SHOWING ANTIVIRAL AND INTERFERONOGENIC ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2449792C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CONGESTIVE CARDIAC FAILURE AND METHOD FOR PREPARING IT | 2011 |
|
RU2479310C2 |
| PHARMACEUTICAL COMPOSITION FOR ALLERGIC DISEASES | 2010 |
|
RU2453315C2 |
| SOLID DRUG FORM OF IMIPRAMINE WITH IMMEDIATE RELEASE AND METHOD OF OBTAINING THEREOF | 2016 |
|
RU2609198C1 |
| PHARMACEUTICAL COMPOSITION OF FABOMOTIZOLE DIHYDROCHLORIDE | 2022 |
|
RU2828872C2 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772875C1 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| HYPOLIPIDEMIC DOSAGE FORM AND METHOD FOR PREPARING IT | 2013 |
|
RU2547574C2 |
